Organization | Save the Children

Save the Children Report issue

Foundation Phase 3 Phase 4

Founded: London United Kingdom (1919)

Organization Overview

First Clinical Trial

2007

NCT00674089

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Save the Children | Save the Children, Federation Inc

Active Ingredients

Drugs in Phase 4 Trials (2)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)

procaine benzylpenicillin (novocaine) (4 trials)

Drugs in Phase 3 Trials (1)

gentamicin (garamycin) (2 trials)

Drugs in Other Trials (4)

coartem (1 trial)

lumefantrine (Coartem) (1 trial)

vitamin a (1 trial)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Neonatal Sepsis (Phase 3)

Pneumonia (Phase 4)

Sepsis (Phase 3)

Toxemia (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial APIs: 7